DAE HWA Pharmaceutical Co. Ltd Net Asset Quality Index
DAE HWA Pharmaceutical Co. Ltd net asset quality index. DAE HWA Pharmaceutical Co. Ltd (067080) has a Net Asset Quality Index of 38.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩220.34 Billion minus total liabilities of ₩134.61 Billion yields net assets of ₩85.72 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check 067080 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of DAE HWA Pharmaceutical Co. Ltd (2011–2025)
Net asset quality index of DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025. This chart shows how DAE HWA Pharmaceutical Co. Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the index stands at 38.9%, representing net assets of ₩85.72 Billion against total assets of ₩220.34 Billion KRW. See 067080 book value for net asset value and shareholders' equity analysis.
DAE HWA Pharmaceutical Co. Ltd Net Asset Quality Index by Year (2011–2025)
DAE HWA Pharmaceutical Co. Ltd net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of DAE HWA Pharmaceutical Co. Ltd.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 37.5% | ₩79.14 Billion | ₩210.86 Billion | ₩131.72 Billion | ▲ +2.6 pp |
| 2024 | 35.0% | ₩72.00 Billion | ₩205.88 Billion | ₩133.89 Billion | ▲ +1.6 pp |
| 2023 | 33.4% | ₩73.23 Billion | ₩219.16 Billion | ₩145.93 Billion | ▼ -5.8 pp |
| 2022 | 39.2% | ₩77.99 Billion | ₩199.06 Billion | ₩121.06 Billion | ▼ -5.7 pp |
| 2021 | 44.9% | ₩79.67 Billion | ₩177.38 Billion | ₩97.70 Billion | ▼ -1.9 pp |
| 2020 | 46.8% | ₩81.98 Billion | ₩175.05 Billion | ₩93.07 Billion | ▼ -0.9 pp |
| 2019 | 47.8% | ₩79.35 Billion | ₩166.15 Billion | ₩86.80 Billion | ▲ +0.3 pp |
| 2018 | 47.4% | ₩76.88 Billion | ₩162.06 Billion | ₩85.17 Billion | ▲ +1.1 pp |
| 2017 | 46.4% | ₩76.75 Billion | ₩165.47 Billion | ₩88.72 Billion | ▲ +3.4 pp |
| 2016 | 43.0% | ₩66.15 Billion | ₩153.80 Billion | ₩87.65 Billion | ▼ -6.0 pp |
| 2015 | 49.0% | ₩61.06 Billion | ₩124.61 Billion | ₩63.55 Billion | ▲ +1.8 pp |
| 2014 | 47.2% | ₩58.51 Billion | ₩124.07 Billion | ₩65.57 Billion | ▼ -3.7 pp |
| 2013 | 50.9% | ₩62.03 Billion | ₩121.87 Billion | ₩59.84 Billion | ▲ +3.7 pp |
| 2012 | 47.2% | ₩61.39 Billion | ₩130.19 Billion | ₩68.80 Billion | ▲ +5.1 pp |
| 2011 | 42.0% | ₩56.99 Billion | ₩135.58 Billion | ₩78.60 Billion | — |